WBA - Walgreens Boots Alliance
9.55
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -10.01 | Insider Own: | 17.88% | Shs Outstand: | 864.00M | Perf Week: | -8.08% |
| Market Cap: | 8.42B | Forward P/E: | 6.69 | EPS next Y: | 1.43 | Insider Trans: | 0.00% | Shs Float: | 709.12M | Perf Month: | 15.90% |
| Income(ttm): | -8636.00M | PEG: | - | EPS next Q: | 0.38 | Inst Own: | 61.07% | Short Float: | 14.28% | Perf Quarter: | 11.57% |
| Revenue(ttm): | 147.66B | P/S: | 0.06 | EPS this Y: | -47.01% | Inst Trans: | 0.12% | Short Ratio: | 4.19 | Perf Half Y: | -39.97% |
| Book/sh: | 12.09 | P/B: | 0.79 | EPS next Y: | -6.44% | ROA: | -9.72% | Short Interest: | 101.28M | Perf Year: | -62.40% |
| Cash/sh: | 3.53 | P/C: | 2.71 | EPS next 5Y: | - | ROE: | -56.69% | 52W Range: | 8.08 - 27.05 | Perf YTD: | -63.42% |
| Dividend Est.: | 1.20 (12.55%) | P/FCF: | - | EPS past 5Y: | - | ROI: | -21.41% | 52W High: | -64.70% | Beta: | 0.62 |
| Dividend TTM: | 1.00 (10.47%) | Quick Ratio: | 0.37 | Sales past 5Y: | 1.77% | Gross Margin: | 16.30% | 52W Low: | 18.19% | ATR (14): | 0.59 |
| Dividend Ex-Date: | Nov 18, 2024 | Current Ratio: | 0.68 | EPS Y/Y TTM: | -180.71% | Oper. Margin: | 1.20% | RSI (14): | 52.24 | Volatility: | 5.29% 6.35% |
| Employees: | 312000 | Debt/Eq: | 3.24 | Sales Y/Y TTM: | 6.17% | Profit Margin: | -5.85% | Recom: | 2.85 | Target Price: | 9.94 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 2.86 | EPS Q/Q: | -1570.28% | Payout: | - | Rel Volume: | 1.23 | Prev Close: | 9.35 |
| Sales Surprise: | 5.02% | EPS Surprise: | 8.85% | Sales Q/Q: | 6.00% | Earnings: | Jan 09 BMO | Avg Volume: | 24.19M | Price: | 9.55 |
| SMA20: | 2.57% | SMA50: | 2.21% | SMA200: | -25.94% | Overbought: -4.08% | Volume: | 29,734,268 | Change: | 2.14% | |
Graham Classic formula value: -76.4
(P/E=8 * 1g) Min value: -71.91
(current P/E * 2g) Max value: -0.0
Average value: -49.44
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.